Cancer Progression and the Immune System

Dr. Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. His research focuses on elucidating molecular mechanisms involved in metabolic disorders, particularly diabetes, including strategies for oral insulin delivery and the use of natural products to mimic signaling pathways. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. Dr. Prabhakar serves on the editorial boards of, and acts as a reviewer for, several national and international scientific journals. He has published extensively in his field and has contributed to numerous books and book chapters. He has also presented his research at scientific meetings and conferences. Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Professor Bonglee Kim, M.D., Ph.D., is a leading academic in Korean Medicine and cancer research. He serves as Professor in the Department of Pathology at the College of Korean Medicine, Kyung Hee University, Seoul, and chairs the Department of Cancer Preventive Material Development. He also leads the Korean Medicine-Based Drug Repositioning Cancer Research Center. Dr. Kim earned his Ph.D. in Korean Medical Science from Kyung Hee University and has held his current professorship since 2015. His prior roles include Postdoctoral Fellow at Texas Tech University (USA) and clinical practice in Seoul. His research focuses on cancer prevention, drug discovery, and repositioning, integrating Korean medicine into novel therapeutic strategies. Dr. Kim has published extensively in high-impact journals and is recognized internationally for advancing innovative approaches to cancer treatment. Dr. Prabha Rajput is an accomplished pharmacologist specializing in neuropharmacology, circadian rhythm research, and mitochondrial biology. She serves as Assistant Professor in the Department of Pharmacology at SVKM’s NMIMS, Shirpur Campus. Previously, she held academic and research roles at ISF College of Pharmacy and Purdue University, contributing to studies on mitochondrial respiration, circadian disruption, and metabolic disorders. Dr. Rajput earned her Ph.D. in Pharmacology from IIT-BHU, focusing on interventions for circadian rhythm disruptions, and an MS (Pharm) in Pharmacology & Toxicology from NIPER, Guwahati. Her research spans melatonin’s protective role in stress-induced addiction, mitochondrial modulators, diabetes-related cognitive impairments, and binge eating neurobiology. She has published widely in leading journals and contributed to books and conferences. Passionate about translational neuroscience, Dr. Rajput integrates laboratory research with teaching, fostering interdisciplinary learning and mentoring emerging scientists.

• 1. Fundamentals of Cancer and Immunity2. Tumor–Immune Interactions and Evasion3. Immunotherapy and Cancer Treatment4. Molecular and Cellular Insights5. Biomarkers, Clinical Response Criteria, and Toxicity Management6. Regulatory RNAs and Extracellular Signaling7. Systems-Level Approaches to Cancer Immunology8. Metabolic and Microbial Regulation of Cancer Immunity9. Future Directions and Challenges